Cargando…
Genetic Heterogeneity and Clonal Evolution of Tumor Cells and their Impact on Precision Cancer Medicine
The efficacy of targeted therapies in leukemias and solid tumors depends upon the accurate detection and sustained targeting of initial and evolving driver mutations and/or aberrations in cancer cells. Tumor clonal evolution of the diverse populations of cancer cells during cancer progression contri...
Autor principal: | Sabaawy, Hatem E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927925/ https://www.ncbi.nlm.nih.gov/pubmed/24558642 http://dx.doi.org/10.4172/2329-6917.1000124 |
Ejemplares similares
-
Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
por: Pamarthy, Sahithi, et al.
Publicado: (2021) -
Genetic heterogeneity and clonal evolution in neuroblastoma
por: Mora, J, et al.
Publicado: (2001) -
Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells
por: Testa, Ugo, et al.
Publicado: (2018) -
Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
por: Cresswell, George D., et al.
Publicado: (2016) -
Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells
por: Testa, Ugo, et al.
Publicado: (2018)